Ivan Juric
Overview
Explore the profile of Ivan Juric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juric I, Fink E, Qiu H, Desprez P, Ravi A, Holton M, et al.
bioRxiv
. 2025 Mar;
PMID: 40027617
Significance: These findings uncover a novel mechanism responsible for bladder cancer recurrence after BCG treatment. Enhanced T cell-urothelial cell communication in recurrent tumors mediated by CD6 and ALCAM leads to...
2.
Yu M, Zemke N, Chen Z, Juric I, Hu R, Raviram R, et al.
Nat Struct Mol Biol
. 2024 Dec;
PMID: 39681766
While a rich set of putative cis-regulatory sequences involved in mouse fetal development have been annotated recently on the basis of chromatin accessibility and histone modification patterns, delineating their role...
3.
Catta-Preta R, Lindtner S, Ypsilanti A, Seban N, Price J, Abnousi A, et al.
Dev Cell
. 2024 Oct;
60(2):288-304.e6.
PMID: 39481376
Transcription factors (TFs) bind combinatorially to cis-regulatory elements, orchestrating transcriptional programs. Although studies of chromatin state and chromosomal interactions have demonstrated dynamic neurodevelopmental cis-regulatory landscapes, parallel understanding of TF interactions...
4.
Ta H, Roy D, Zhang K, Alban T, Juric I, Dong J, et al.
Sci Immunol
. 2024 May;
9(95):eadi7418.
PMID: 38758807
Immune checkpoint blockade is a promising approach to activate antitumor immunity and improve the survival of patients with cancer. V-domain immunoglobulin suppressor of T cell activation (VISTA) is an immune...
5.
Zhang K, Zakeri A, Alban T, Dong J, Ta H, Zalavadia A, et al.
Cell Rep
. 2024 Jan;
43(1):113661.
PMID: 38175754
Myeloid-derived suppressor cells (MDSCs) impair antitumor immune responses. Identifying regulatory circuits during MDSC development may bring new opportunities for therapeutic interventions. We report that the V-domain suppressor of T cell...
6.
Jakus D, Solic I, Juric I, Borovac J, Situm M
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445294
This study investigated the impact of the initial clinical presentation of bladder cancer on tumor characteristics. A cross-sectional, retrospective study was performed, and it involved 515 patients who underwent transurethral...
7.
Catta-Preta R, Lindtner S, Ypsilanti A, Price J, Abnousi A, Su-Feher L, et al.
bioRxiv
. 2023 Jul;
PMID: 37425940
Transcription factors (TFs) bind combinatorially to genomic cis-regulatory elements (cREs), orchestrating transcription programs. While studies of chromatin state and chromosomal interactions have revealed dynamic neurodevelopmental cRE landscapes, parallel understanding of...
8.
Juric I, Nesek Adam V
Acta Clin Croat
. 2022 Oct;
61(Suppl 1):44-48.
PMID: 36304812
Given the importance of early recognition of acute venous thromboembolism (VTE) and the nonspecificity of its symptoms and signs, it is essential to follow the guidelines for diagnostic and therapeutic...
9.
Ma X, Riaz N, Samstein R, Lee M, Makarov V, Valero C, et al.
Nat Genet
. 2022 Jul;
54(7):996-1012.
PMID: 35817971
Defects in pathways governing genomic fidelity have been linked to improved response to immune checkpoint blockade therapy (ICB). Pathogenic POLE/POLD1 mutations can cause hypermutation, yet how diverse mutations in POLE/POLD1...
10.
Ypsilanti A, Pattabiraman K, Catta-Preta R, Golonzhka O, Lindtner S, Tang K, et al.
Proc Natl Acad Sci U S A
. 2021 Dec;
118(51).
PMID: 34921112
We uncovered a transcription factor (TF) network that regulates cortical regional patterning in radial glial stem cells. Screening the expression of hundreds of TFs in the developing mouse cortex identified...